PE20000512A1 - Capsula doble para la administracion de principios activos en terapias multiples - Google Patents

Capsula doble para la administracion de principios activos en terapias multiples

Info

Publication number
PE20000512A1
PE20000512A1 PE1998001235A PE00123598A PE20000512A1 PE 20000512 A1 PE20000512 A1 PE 20000512A1 PE 1998001235 A PE1998001235 A PE 1998001235A PE 00123598 A PE00123598 A PE 00123598A PE 20000512 A1 PE20000512 A1 PE 20000512A1
Authority
PE
Peru
Prior art keywords
capsule
administration
active principles
pharmaceutical dosage
double capsule
Prior art date
Application number
PE1998001235A
Other languages
English (en)
Inventor
Giovanni Sanso
Original Assignee
Axcan Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11378381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20000512(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Axcan Pharma Inc filed Critical Axcan Pharma Inc
Publication of PE20000512A1 publication Critical patent/PE20000512A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA FORMA DE DOSIFICACION FARMACEUTICA PARA LA ADMINISTRACION DE LOS PRINCIPIOS ACTIVOS EN TERAPIAS MULTIPLES, QUE CONSISTE EN UNA CAPSULA DOBLE, DONDE UNA CAPSULA INTERNA SE COLOCA DENTRO DE UNA CAPSULA EXTERNA, CONTENIENDO CADA UNA DE ELLAS UNO O MAS PRINCIPIOS ACTIVOS. DICHA CAPSULA DOBLE SE USA EN TERAPIAS TRIPLES O CUADRUPLES CONTRA LOS MICROORGANISMOS HELICOBACTER PYLORI. ESTA FORMA DE DOSIFICACION FARMACEUTICA CONSISTE EN PROVEER UNA POSOLOGIA SIMPLE PARA LA ADMINISTRACION DE DOS Y MAS PRINCIPIOS ACTIVOS, PERMITIENDO QUE ESTOS SE ACTIVEN EN LOS INTERVALOS CORRECTOS Y EN LAS CANTIDADES PREESTABLECIDAS, EVITANDO QUE SE PRODUZCAN INTERACCIONES ENTRE ELLOS. EN OTRO ASPECTO, LA FORMA DE DOSIFICACION FARMACEUTICA TIENE UNA CAPSULA EXTERNA, QUE CONTIENE SUBCITRATO DE BISMUTO Y METRONIDAZOL Y UNA INTERNA QUE CONTIENE TETRACICLINA Y, EN FORMA OPCIONAL, OMEPRAZOL, QUE SE EMPLEA PARA LA ERRADICACION DE HELICOBACTER PYLORI
PE1998001235A 1997-12-17 1998-12-16 Capsula doble para la administracion de principios activos en terapias multiples PE20000512A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI002788A IT1296980B1 (it) 1997-12-17 1997-12-17 Capsula doppia come forma farmaceutica per la somministrazione di principi attivi in terapie multiple

Publications (1)

Publication Number Publication Date
PE20000512A1 true PE20000512A1 (es) 2000-06-13

Family

ID=11378381

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001235A PE20000512A1 (es) 1997-12-17 1998-12-16 Capsula doble para la administracion de principios activos en terapias multiples

Country Status (25)

Country Link
US (1) US6350468B1 (es)
EP (1) EP1037614B1 (es)
JP (1) JP4615713B2 (es)
KR (1) KR100509351B1 (es)
CN (1) CN1147292C (es)
AR (1) AR014126A1 (es)
AT (1) ATE254910T1 (es)
AU (1) AU743090B2 (es)
BR (1) BR9812803A (es)
CA (1) CA2315408C (es)
CZ (1) CZ299181B6 (es)
DE (1) DE69820108T2 (es)
DK (1) DK1037614T3 (es)
ES (1) ES2212391T3 (es)
HU (1) HU225690B1 (es)
ID (1) ID26340A (es)
IT (1) IT1296980B1 (es)
MY (1) MY121713A (es)
NO (1) NO329126B1 (es)
NZ (1) NZ505655A (es)
PE (1) PE20000512A1 (es)
PL (1) PL192541B1 (es)
PT (1) PT1037614E (es)
TR (1) TR200001761T2 (es)
WO (1) WO1999030693A2 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
GB0017673D0 (en) * 2000-07-20 2000-09-06 Mw Encap Limited Delivery device
AU2001272645A1 (en) * 2000-07-20 2002-02-05 Mw Encap Limited Delivery device
US20040105883A1 (en) * 2001-04-17 2004-06-03 Ping Gao Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
US20040105885A1 (en) * 2001-04-17 2004-06-03 Ping Gao Gelatin capsule exhibiting reduced cross-linking
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
US6726809B2 (en) * 2001-09-26 2004-04-27 Albany International Corp. Industrial process fabric
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AU2003290377A1 (en) * 2003-01-03 2004-07-29 Marton Milankovits Pharmaceutical compositions comprising an antibacterial agent nd antifungal agent and a nitroimidazole for the treatment and prevention of genitourinary infections and their extragenital complications
US20050053648A1 (en) * 2003-09-08 2005-03-10 Chalmers Anne Marie Medication delivery device
WO2005039474A1 (en) * 2003-10-21 2005-05-06 Ambo Innovation Llc Digestible and volume adjustable multi medication delivery device
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
CN100350898C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方三七双相胶囊及其制备方法
CN100350899C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 冠心丹参双相胶囊及其制备方法
CN100350900C (zh) * 2005-05-23 2007-11-28 江西本草天工科技有限责任公司 复方降香双相胶囊及其制备方法
US8865197B2 (en) * 2005-09-06 2014-10-21 Israel Oceanographic And Limnological Research Ltd. Food formulation for aquatic animals with integrated targeted delivery of bioactive agents
CA2625776A1 (en) * 2005-10-14 2007-04-26 Microdose Technologies, Inc. Pharmaceutical packaging of an oral dosage combination
CN100393359C (zh) * 2005-12-13 2008-06-11 济南百诺医药科技开发有限公司 根除幽门螺旋杆菌的多单元组合物
JP5628480B2 (ja) 2006-03-09 2014-11-19 グラクソスミスクライン エルエルシー 医薬成分を含有するコーティングカプセル
US8784886B2 (en) * 2006-03-09 2014-07-22 GlaxoSmithKline, LLC Coating capsules with active pharmaceutical ingredients
US9233092B2 (en) * 2006-07-25 2016-01-12 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
CN101513395B (zh) * 2008-02-20 2011-01-12 单宝华 紫杉醇类双层软胶囊口服制剂药物
DE102009001334B4 (de) 2009-03-04 2017-02-23 Stefan Brosig Einfache magensaftresistente Verkapselung, z.B. von Ingwer und anderen empfindlichen Stoffen
CN101607086B (zh) * 2009-07-21 2011-11-02 山西安特生物制药股份有限公司 一种复方铋剂组合物及其制备方法
TWI463998B (zh) 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
CN102349887A (zh) * 2011-08-02 2012-02-15 天津市嵩锐医药科技有限公司 双氯芬酸钠对乙酰氨基酚胃肠型胶囊药物组合物
ITMI20120350A1 (it) * 2012-03-06 2013-09-07 Ultimate Italia S A S Di Levantino Enrico E C Forma di dosaggio per somministrazione orale di principi attivi
US20160008371A1 (en) * 2014-07-14 2016-01-14 Autotelic Llc Fixed dose combination for pain relief without edema
US9700514B1 (en) * 2014-08-20 2017-07-11 Darren Rubin Single solid oral dosage forms for treating Helicobacter pylori infection and duodenal ulcer disease
CN105106162A (zh) * 2015-08-21 2015-12-02 四川百利药业有限责任公司 一种治疗幽门螺杆菌所引起溃疡的复方片剂及其制备方法
US10772831B2 (en) * 2016-06-22 2020-09-15 University Of Florida Research Foundation, Inc. Pharmaceutical capsules for medication adherence monitoring and methods of forming the same
CN108186968B (zh) * 2018-01-08 2021-07-20 江苏聚荣制药集团有限公司 温胃舒胶囊

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072528A (en) 1957-07-13 1963-01-08 Med Fabrik Chemisch Pharmazeut Ingestible dry microorganism preparations
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
DE2729068A1 (de) * 1977-06-28 1979-01-11 Rainer Dr Med Liedtke Verfahren zur freisetzungssteuerung von arzneimitteln aus kapseln
CA1143287A (en) * 1981-08-11 1983-03-22 William C. Stewart Waterproof edible encapsulation for prophylactic drugs
DK150008C (da) 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4642233A (en) 1982-03-22 1987-02-10 Alza Corporation Gastrointestinal drug delivery system comprising a hydrogel reservoir containing a plurality of tiny pills
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
JPS59131355A (ja) 1983-01-17 1984-07-28 森下仁丹株式会社 多重軟カプセルの製法
JPS60193917A (ja) * 1984-03-14 1985-10-02 R P Shiila- Kk 多重構造軟カプセル剤
US4627808A (en) 1985-05-31 1986-12-09 Hughes Raymond J Apparatus for making capsule having plural chambers
US5256684A (en) 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
US4904476A (en) 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4793493A (en) 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US4936461A (en) 1986-09-18 1990-06-26 Makiej Jr Walter J Multidose capsules
US4822619A (en) 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5394980A (en) 1987-06-30 1995-03-07 Tsai; Min H. Multicompartment mixing capsule
US5196205A (en) 1987-10-12 1993-03-23 Borody Thomas J Method for treatment of gastro intestinal disorders
US5192752A (en) 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US5582837A (en) 1992-03-25 1996-12-10 Depomed, Inc. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5472695A (en) 1992-06-25 1995-12-05 Technion Research And Development Foundation Ltd. Therapeutic application of a thyme extract and in - vitro methods for inhibiting the growth and urease activity of helicobacter pylori
US5310555A (en) 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
CA2156726C (en) * 1993-02-26 2000-10-17 Paula Denise Davis Bisacodyl dosage form
WO1996010996A1 (en) 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5560912A (en) 1994-06-27 1996-10-01 Technion Research & Development Foundation Ltd. Method for inhibiting growth of helicobacter pylori
AUPM695294A0 (en) 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit

Also Published As

Publication number Publication date
IT1296980B1 (it) 1999-08-03
CN1285741A (zh) 2001-02-28
KR20010033244A (ko) 2001-04-25
JP4615713B2 (ja) 2011-01-19
CA2315408C (en) 2005-05-24
HK1034897A1 (en) 2001-11-09
ES2212391T3 (es) 2004-07-16
HU225690B1 (en) 2007-06-28
CZ20002231A3 (cs) 2000-11-15
PL192541B1 (pl) 2006-11-30
TR200001761T2 (tr) 2000-10-23
AR014126A1 (es) 2001-02-07
EP1037614B1 (en) 2003-11-26
DK1037614T3 (da) 2004-04-05
WO1999030693A3 (en) 1999-09-02
NO20003159L (no) 2000-08-16
HUP0100095A2 (hu) 2001-06-28
CA2315408A1 (en) 1999-06-24
BR9812803A (pt) 2000-10-03
ID26340A (id) 2000-12-14
KR100509351B1 (ko) 2005-08-22
WO1999030693A2 (en) 1999-06-24
AU2413599A (en) 1999-07-05
EP1037614A2 (en) 2000-09-27
PT1037614E (pt) 2004-04-30
CN1147292C (zh) 2004-04-28
DE69820108D1 (de) 2004-01-08
AU743090B2 (en) 2002-01-17
NZ505655A (en) 2003-09-26
MY121713A (en) 2006-02-28
DE69820108T2 (de) 2004-09-09
NO329126B1 (no) 2010-08-30
CZ299181B6 (cs) 2008-05-14
ITMI972788A1 (it) 1999-06-17
HUP0100095A3 (en) 2001-12-28
NO20003159D0 (no) 2000-06-16
ATE254910T1 (de) 2003-12-15
JP2002508312A (ja) 2002-03-19
US6350468B1 (en) 2002-02-26
PL341737A1 (en) 2001-05-07

Similar Documents

Publication Publication Date Title
AR014126A1 (es) Uso de una sal soluble de bismuto, un primer antibiotico y un segundo antibiotico y una forma de dosificacion faramaceutica
ES2189232T3 (es) Microgranulos de omeprazol protegidos gastricamente, procedimiento para su preparacion y preparaciones farmaceuticas.
ES8705762A1 (es) Procedimiento para preparar un agente analgesicamente activo a base de 2-amino-3-carboetoxiamino-6-(4-fluorobencilamino)-piridina y por lo menos un agente antiflogistico no esteroidal
AR039132A2 (es) Metodo para administrar un agente farmaceuticamente activo al ojo teniendo dicho ojo una esclerotica, una capsula de tenon y una macula
GT200000041A (es) Uso de inhibidores de cyp2d6 en terapias de combinacion.
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
ES2117146T3 (es) Tableta farmaceutica capaz de liberar una o varias sustancias medicamentosas a diferentes velocidades.
DOP2001000229A (es) Forma de dosificación de fármaco activada por hidrogel
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
ECSP088342A (es) Dispositivo dispensador, dispositivo de almacenamiento y método para dispensar una formulacion
ES2139002T3 (es) Terapia medicamentosa citotoxica.
AR026978A1 (es) Sistema de medicamentos en polvo e inhalador provisto con el
NO874960L (no) Flytende doseringsform for oral administrasjon av et farmasoeytisk aktivt stoff.
ES2123595T3 (es) Formas de dosis unitarias farmaceuticas topicas semi-solidas para la terapia percutanea.
BR0014818A (pt) Imidazo-3-il-aminas bicìclicas procedimento de preparação e medicamentos que contém como substância ativa pelo menos uma imidazo-3-il-amina bicìclica
AR032293A1 (es) Estuche farmaceutico
ES2168241T1 (es) Preparacion farmaceutica que contiene tolperisona para administrar por via oral.
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
DK1345595T3 (da) Ionstyrke-uafhængig farmaceutisk formulering med depotfrigivelse
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
ES2179533T3 (es) Formulacion de medicamento con liberacion controlada del principio activo.
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
HUP0202424A2 (hu) Benzazepin-N-ecetsav származékokat tartalmazó oxidatív-toxikus, elsősorban kardiotoxikus anyagok ellen védőhatást kifejtő gyógyszerkészítmény
PE25299A1 (es) Paquete de complimiento y metodo para mejorar o ayudar al paciente a cumplir con un regimen de medicacion complejo
AR022621A1 (es) Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term